GlaxoSmithkline Consumer Healthcare has reported results for the second quarter ended June 30, 2012.
The company’s net profit jumped by 29.27% at Rs 106.60 crore for the quarter under review as compared to Rs 82.46 crore for the quarter ended June 30, 2011. Total income of the company has increased by 14.16% to Rs 786.96 crore for the Q2FY13 from Rs 689.35 crore for the similar quarter of the previous year.
GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.